Hippocampal neurogenesis and pro-neurogenic therapies for Alzheimer's disease.

Abstract

Adult hippocampal neurogenesis (AHN) facilitates hippocampal circuits plasticity and regulates hippocampus-dependent cognition and emotion. However, AHN malfunction has been widely reported in both human and animal models of Alzheimer's disease (AD), the most common form of dementia in the elderly. Pro-neurogenic therapies including rescuing innate AHN, cell engraftment and glia-neuron reprogramming hold great potential for compensating the neuronal loss and rewiring the degenerated neuronal network in AD, but there are still great challenges to be overcome. This review covers recent advances in unraveling the involvement of AHN in AD and highlights the prospect of emerging pro-neurogenic remedies.

• Authors: Jie Zheng
• Journal: Animal models and experimental medicine (Animal Model Exp Med) Vol. 5 Issue 1 Pg. 3-14 (02 2022) ISSN: 2576-2095 [Electronic] United States
• PMID: 35229998 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2022 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

Topics

• Aged
• Alzheimer Disease
• Animals
• Cognition (physiology)
• Hippocampus
• Humans
• Neurogenesis (physiology)
• Neurons